EXR
53
-2
SYF
83
-5
HIG
52
-4
GOOGL
67
8
PSX
35
-5
EOG
34
-2
DAL
62
-2
PEP
47
3
TGNA
56
2
KLAC
54
-3
KMI
65
-4
GIS
37
3
HAL
39
2
MMM
35
-3
NTAP
61
-6
EBAY
44
-4
ESS
57
-2
KSS
26
-2
GWW
58
-2
CSX
53
3
EXR
53
-2
SYF
83
-5
HIG
52
-4
GOOGL
67
8
PSX
35
-5
EOG
34
-2
DAL
62
-2
PEP
47
3
TGNA
56
2
KLAC
54
-3
KMI
65
-4
GIS
37
3
HAL
39
2
MMM
35
-3
NTAP
61
-6
EBAY
44
-4
ESS
57
-2
KSS
26
-2
GWW
58
-2
CSX
53
3
Financhill
Back

Theravance Biopharma Stock Predictions

Better Than Oil Stocks

CLICK HERE TO FIND OUT MORE
Buy
70

TBPH
Theravance Biopharma

Last Price:
10.04
Seasonality Move:
7.6%

7 Day Trial

ALL ACCESS PASS

$ 7

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)

Theravance Biopharma Stock Forecast

  • Over the next 52 weeks, Theravance Biopharma has on average historically risen by 1.4% based on the past 10 years of stock performance.
  • Theravance Biopharma has risen higher in 3 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 30%
  • Is Theravance Biopharma Stock Undervalued?
    The current Theravance Biopharma [TBPH] share price is $10.04. The Score for TBPH is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • TBPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Theravance Biopharma Stock Go Up Next Year?

  • Over the next 52 weeks, Theravance Biopharma has on average historically risen by 1.4% based on the past 10 years of stock performance.

Theravance Biopharma Stock Rating

Buy
70
Theravance Biopharma (TBPH) is a Buy

Is Theravance Biopharma overpriced?

  • Theravance Biopharma has risen higher in 3 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 30%

Theravance Biopharma Stock Price History

Is TBPH stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TBPH is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Cayman Islands
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
theravance.com

52-Week Data

52-Week High:
11.71
52-Week Low:
7.44

Prediction Charts

Market Cap:
493.71M
Price in USD:
10.04
Volume:
129.67K
Beta:
0.74

Technical Analysis

SMA50:
8.95
SMA100:
8.73
SMA200:
8.88
52-Wk Change:
-6.86%

Stock Predictions

  • Is Theravance Biopharma stock public?
    Yes, Theravance Biopharma is a publicly traded company.
  • What is the Theravance Biopharma stock quote today?
    The Theravance Biopharma stock price is 10.04 USD today.
  • How to buy Theravance Biopharma stock online?
    You can buy Theravance Biopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-21 9.92 9.61 9.97 9.59
Nov-22 9.59 9.47 9.75 9.37
Nov-25 9.52 9.47 9.76 9.47
Nov-26 9.50 9.24 9.50 9.20
Nov-27 9.32 9.42 9.56 9.25
Nov-29 9.46 9.25 9.49 9.20
Dec-2 9.14 9.44 9.53 9.14
Dec-3 9.45 9.84 9.84 9.37
Dec-4 9.84 9.59 9.98 9.55
Dec-5 9.58 9.84 9.88 9.55
Dec-6 9.81 9.88 10.01 9.81
Dec-9 9.89 9.99 10.25 9.89
Dec-10 9.97 10.08 10.15 9.94
Dec-11 10.08 10.04 10.10 9.96

Theravance Biopharma Earnings

Theravance Biopharma Earnings Report: Per Share Theravance Biopharma Earnings Q1 Q2 Q3 and Q4 last year and next year.

Theravance Biopharma Forecast Revenue Growth

Theravance Biopharma Stock Analysis: Historical quarterly revenues per share for Theravance Biopharma and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.33 per share, and an increase next year of $1.08 per share.

* Theravance Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.